Savina Yann, Leal Sandra, Zellner Pascal, Becker François, Piris Monica, Cauchy Emmanuel
1 IFREMMONT (Institut de Formation et de Recherche en Médecine de Montagne) Hôpital de Chamonix, Hôpital de Chamonix, Chamonix, France.
2 Médecine Vasculaire, Hôpitaux Universitaires de Genève, Genève, Switzerland.
High Alt Med Biol. 2019 Mar;20(1):56-60. doi: 10.1089/ham.2018.0069. Epub 2019 Jan 7.
Hypothermia and frostbite occur when there is a significant decrease in central and peripheral body temperature in individuals exposed to cold windy conditions, often at high altitude or in a mountain environment. Portable hyperbaric chambers increase the barometric pressure and thereby the partial pressure of oxygen inside the chamber, and their use is a well-known treatment for altitude illness. This study aims to show that a portable hyperbaric chamber could also be used to treat hypothermia and frostbite in the field, when rescue or descent is impossible or delayed.
During a European research program (SOS-MAM, Flow Pulse study) measurements were taken from 27 healthy nonacclimatized voluntary subjects (21 men, 6 women, mean age 41 ± 17) at an altitude of 3800 m (Chamonix Mountain Lab, Aiguille du Midi, France) right before and immediately after spending 1 hour in a portable hyperbaric chamber at 300 mbar. We measured digital cutaneous temperature (Tcut), digital cutaneous blood flow (Fcut), digital tissue oxygenation (TPO), blood oxygen saturation (SO), heart rate, and core temperature. Air temperature inside the chamber (Tchamb) was measured throughout the whole session.
We observed significant increases in Tchamb: 9.3°C compared with the outside temperature, Tcut: +7.5°C (±6.2°C 71%), Fcut: +58 (±89) (+379%), TPO: +18 mmHg (±11.9) (304%), and SO: 13%.
This study shows that a portable hyperbaric chamber can be used to treat frostbite and/or hypothermia in the field at altitude when descent or rescue is impossible or even simply delayed.